Prosecution Insights
Last updated: August 14, 2026

LTS Lohmann Therapie-Systeme AG

22 pending office actions • 12 art units • 21 examiners • 0 of 22 (0%) have an AI response strategy ready • 17 patents granted in the last 365 days

Portfolio Summary

22
Total Pending OAs
10
Non-Final OAs
11
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
1
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (1)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

8
Hard (36%)
13
Medium (59%)
1
Easy (5%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only11 (50%)
§102 only1 (5%)
Double-patenting only1 (5%)
Double-patenting + other1 (5%)
Multi-statute (no §101)8 (36%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

16
Life Sciences
73% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
5% of docket
5
Mechanical / Eng
23% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

220 h
Manual time on pending OAs
44 h
Time saved (low, 20%)
77 h
Time saved (mid, 35%)
1.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ZHANG SPIERING, DONGXIU 2 38.1% +88.9%
SHOMER, ISAAC 1 63.3% +30.3%
ALLEY, GENEVIEVE S 1 60.3% +48.4%
MEYERS, ELIZABETH ANNE 1 28.6% +90.9%
STRACHAN, KATE ELIZABETH 1 45.5% +30.9%
ROY, DEBJANI 1 75.2% +14.9%
HARM, NICKOLAS R 1 79.3% +5.9%
BAZARGANI, ARYA AHMADI 1 75.0% +37.5%
NGUYEN, LAM S 1 78.8% +0.9%
OLSEN, KAELEIGH ELIZABETH 1 40.7% +72.7%

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18686139 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID MEYERS, ELIZABETH ANNE 45d overdue
17597385 TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE AGENT-CONTAINING LAYER COMPRISING A SILICONE-CONTAINING POLYMER AND A SKIN CONTACT LAYER COMPRISING A SILICONE GEL ADHESIVE SCHLIENTZ, NATHAN W 17d overdue
17786223 TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE ZHANG SPIERING, DONGXIU 19d
16765775 WATER-SOLUBLE POLYMER ADHESIVE LAYERS HELM, CARALYNNE E 34d
18272441 MULTI-LAYER ORAL THIN FILM OLSEN, KAELEIGH ELIZABETH 47d
18692408 RAPIDLY DISINTEGRATING ORAL THIN-FILMS/FOAMS HAVING A HIGH ACTIVE-INGREDIENT CONTENT BASED ON A MIXTURE OF POLYVINYL ALCOHOLS HAVING VARIOUS MOLECULAR WEIGHTS ALLEY, GENEVIEVE S
18283560 Method and Device for Manufacturing an Adherent Film Composite HARM, NICKOLAS R
18210144 MICRONEEDLE SYSTEM FOR THE DELIVERY OF INTERFERON GREENE, IVAN A

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18686139 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID MEYERS, ELIZABETH ANNE 45d overdue
17786223 TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE ZHANG SPIERING, DONGXIU 19d
18272441 MULTI-LAYER ORAL THIN FILM OLSEN, KAELEIGH ELIZABETH 47d
18699714 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF TIZANIDINE SHOMER, ISAAC
18692408 RAPIDLY DISINTEGRATING ORAL THIN-FILMS/FOAMS HAVING A HIGH ACTIVE-INGREDIENT CONTENT BASED ON A MIXTURE OF POLYVINYL ALCOHOLS HAVING VARIOUS MOLECULAR WEIGHTS ALLEY, GENEVIEVE S
18572041 Method and Device for Impregnating a Film, and Method for Manufacturing a Transdermal Therapeutic System STRACHAN, KATE ELIZABETH
18289948 Method and Device for Manufacturing Microneedle Elements and a Microneedle Element ROY, DEBJANI
18548690 ORAL THIN FILM BAZARGANI, ARYA AHMADI

Top Art Units

Art UnitApps
3783 4
1613 3
1619 3
1616 3
1617 2
1612 1
3781 1
1741 1
1745 1
2853 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18699714 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF TIZANIDINE SHOMER, ISAAC 1612 §103 Non-Final OA Pending Apr 09, 2024
18692408 RAPIDLY DISINTEGRATING ORAL THIN-FILMS/FOAMS HAVING A HIGH ACTIVE-INGREDIENT CONTENT BASED ON A MIXTURE OF POLYVINYL ALCOHOLS HAVING VARIOUS MOLECULAR WEIGHTS ALLEY, GENEVIEVE S 1617 §103§112 Non-Final OA Pending Mar 15, 2024
18686139 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID MEYERS, ELIZABETH ANNE 1617 §103DP Final Rejection 45d overdue Pending Feb 23, 2024
18572041 Method and Device for Impregnating a Film, and Method for Manufacturing a Transdermal Therapeutic System STRACHAN, KATE ELIZABETH 3781 §103 Final Rejection Pending Dec 19, 2023
18289948 Method and Device for Manufacturing Microneedle Elements and a Microneedle Element ROY, DEBJANI 1741 §103 Non-Final OA Pending Nov 08, 2023
18283560 Method and Device for Manufacturing an Adherent Film Composite HARM, NICKOLAS R 1745 §103§112 Final Rejection Pending Sep 22, 2023
18548690 ORAL THIN FILM BAZARGANI, ARYA AHMADI 1613 DP Final Rejection Pending Sep 01, 2023
18272678 Test Equipment for Microneedle Systems, and a Test System and a Method for Testing a Microneedle Application NGUYEN, LAM S 2853 §103 Non-Final OA Pending Jul 17, 2023
18272441 MULTI-LAYER ORAL THIN FILM OLSEN, KAELEIGH ELIZABETH 1619 §103§112Other Non-Final OA 47d Pending Jul 14, 2023
18210144 MICRONEEDLE SYSTEM FOR THE DELIVERY OF INTERFERON GREENE, IVAN A 1619 §102§103§112Other Non-Final OA Pending Jun 15, 2023
18266740 Active Ingredient Delivery System MARRISON, SAMUEL JOSEPH 3783 §103 Non-Final OA Pending Jun 12, 2023
18036436 Intradermal Active Ingredient Delivery System PATEL, SHEFALI DILIP 3783 §102§103§112 Final Rejection Pending May 11, 2023
18019505 ESKETAMINE-SUSPENSION-TTS ZHANG SPIERING, DONGXIU 1616 §103 Non-Final OA Pending Feb 03, 2023
17786235 TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE KASSA, TIGABU 1619 §103 Final Rejection Pending Jan 31, 2023
17913747 DMEU ENHANCER SONG, JIANFENG 1613 §103 Final Rejection 45d overdue Pending Sep 22, 2022
17787874 SOLUBLE REAR LAYER FOR OTF PRAGANI, RAJAN 1614 §103 Non-Final OA Pending Jun 21, 2022
17786223 TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE ZHANG SPIERING, DONGXIU 1616 §103§112Other Final Rejection 19d Pending Jun 16, 2022
17638119 Microarray Applicator and Method for Displacing a Plunger Acting Upon the Microarray HALL, DEANNA K 3783 §102 Non-Final OA Pending Feb 24, 2022
17597385 TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE AGENT-CONTAINING LAYER COMPRISING A SILICONE-CONTAINING POLYMER AND A SKIN CONTACT LAYER COMPRISING A SILICONE GEL ADHESIVE SCHLIENTZ, NATHAN W 1616 §103§112 Non-Final OA 17d overdue Pending Jan 04, 2022
17423509 Applicator DIPERT, FORREST BLAKE 3783 §103 Final Rejection Pending Jul 16, 2021
17421265 ORAL THIN FILM KIM, DANIELLE A 1613 §103 Final Rejection 37d overdue Pending Jul 07, 2021
16765775 WATER-SOLUBLE POLYMER ADHESIVE LAYERS HELM, CARALYNNE E 1615 §103§112 Final Rejection 34d Pending May 20, 2020

Managing LTS Lohmann Therapie-Systeme AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month